中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

联合半肝切除的肝门部胆管癌根治术后发生急性肝衰竭的危险因素分析

张毅 张杰峰 张艳林 张希 曾建挺 邓和军

引用本文:
Citation:

联合半肝切除的肝门部胆管癌根治术后发生急性肝衰竭的危险因素分析

DOI: 10.3969/j.issn.1001-5256.2016.10.023
详细信息
  • 中图分类号: R735.8

Risk factors for acute liver failure after radical surgery combined with hemihepatectomy for hilar cholangiocarcinoma

  • 摘要:

    目的探讨联合半肝切除的肝门部胆管癌(HC)根治术后发生急性肝衰竭的危险因素。方法回顾性分析重庆市肿瘤研究所2000年1月-2014年12月收治的行联合半肝切除的HC根治术的126例患者的临床资料,包括性别、年龄、术前血清TBil、Alb水平,是否保留肝动脉血供,是否行非选择性肝血流阻断,术中失血量和手术时间。计数资料组间比较采用χ2检验,进一步采用Logistic多因素回归分析患者术后发生急性肝衰竭的独立危险因素。结果共有17例(13.49%)发生急性肝衰竭,其中死亡11例(8.73%)。术前血清TBil>200μmol/L[比值比(OR)=1.78,95%可信区间(95%CI):1.053.04,P=0.029]、术中失血量>800 ml(OR=2.64,95%CI:1.333.95,P=0.037)、未保留肝动脉血供(OR=3.57,95%CI:2.215.09,P=0.002)、采用非选择性肝血流阻断(OR=1.36,95%CI:0.791.78,P=0.037)是术后发生急性肝衰...

     

  • [1]IZBICKI JR,TSUI TY,BOHN BA,et al.Surgical strategies in patientswith advanced hilarcholangiocarcinoma(klatskin tumor)[J].J Gastrointest Surg,2013,17(3):581-585.
    [2] PAPOULAS M,LUBEZKY N,GOYKHMAN Y,et al.Contemporary surgical approach to hilarcholangiocarcinoma[J].Isr Med Assoc J,2011,13(2):99-103.
    [3] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,CMA;Severe Liver Disease and Artificial Liver Group,Chinese Society of Hepatology,CMA.Guideline for diagnosis and treatment of liver failure[J].Chin J Infect Dis,2013,31(3):129-137.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝功能衰竭诊治指南(2012)[J].中华传染病杂志,2013,31(3):129-137.
    [4]NAGINO M,NIMURA Y,NISHIO H,et al.Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilarcholangiocarcinoma:an audit of 50 consecutive cases[J].Ann Surg,2010,252(1):115-123.
    [5]van der GAAG NA,KLOEK JJ,de BAKKER JK,et al.Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma[J].Ann Onc,2012,10(23):2642-2649.
    [6]KOW AW,WOOK CD,SONG SC,et al.Role of caudate lobectonmy in typeⅢa andⅢb hilar cholangiocarcinoma:a 15-year experience in a tertiary institution[J].World J Surg,2012,36(5):1112-1121.
    [7]NATSUME S,EBATA T,YOKOYAMA Y,et al.Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma:an appraisal and comparison with left hepatectomy[J].Ann Surg,2012,255(4):754-762.
    [8]PAPOULAS M,LUBEZKY N,GOYKHMAN Y,et al.Contemporary surgical approach to hilarcholangiocarcinoma[J].Isr Med Assoc J,2011,13(2):99-103.
    [9]QIU J,CHEN S,PANKAJ P,et al.Portal vein arterialization as a bridge procedure against acute liver failure after extended hepatectomy for hilar cholangiocarcinoma[J].Surg Innov,2014,21(4):372-375.
    [10]KOERKAMP BG,WIGGERS JK,GONEN M,et al.Survival after resection of perihilar cholangiocarcinoma—development and external validation of a prognostic nomogram[J].Ann Onc,2015,9(26):1930-1935.
    [11]CHRIS J,LEIGH K,COLIN B,et al.Acute liver failure following hepatic resection:incidence,presentation,prevention and management in ICU[J].J Intensive Care Soc,2013,4(14):133-140.
    [12]YOUICHI M,SHIGEKI N,RYUICHI N,et al.The correlation between posthepatectomy liver failure(PHLF)by ISGLS and residual liver function using preoperative 99m Tc-GSA scintigraphy[J].J Nucl Med,2015,5(56):1677.
    [13]TAMOTO E,HIRANO S,TSUCHIKAWA T,et al.Portal vein resection using the no-touch technique with a hepatectomy for hilarcholangiocarcinoma[J].HPB(Oxford),2013,16(1):56-61.
  • 加载中
计量
  • 文章访问数:  2355
  • HTML全文浏览量:  15
  • PDF下载量:  424
  • 被引次数: 0
出版历程
  • 出版日期:  2016-10-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回